Edilburga Reyes-Jimenez
Overview
Explore the profile of Edilburga Reyes-Jimenez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
71
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Santos-Alvarez J, Velazquez-Enriquez J, Reyes-Jimenez E, Ramirez-Hernandez A, Iniguez-Palomares R, Rodriguez-Beas C, et al.
Mol Biol Rep
. 2024 Nov;
51(1):1166.
PMID: 39560703
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic and highly fatal disease characterized by excessive accumulation of extracellular matrix (ECM), foci of myofibroblasts, and a usual pattern of interstitial pneumonia....
2.
Velazquez-Enriquez J, Santos-Alvarez J, Ramirez-Hernandez A, Reyes-Jimenez E, Perez-Campos Mayoral L, de Los Angeles Romero-Tlalolini M, et al.
Biochem Biophys Res Commun
. 2024 Sep;
734:150672.
PMID: 39260206
Aims: Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung condition, the cause of which remains unknown and for which no effective therapeutic treatment is currently available. Chlorogenic acid...
3.
Reyes-Avendano I, Villasenor-Altamirano A, Reyes-Jimenez E, Velazquez-Enriquez J, Baltierrez-Hoyos R, Pina-Vazquez C, et al.
Dig Liver Dis
. 2024 Jun;
56(11):1887-1896.
PMID: 38824040
Background: The identification of biomarkers for the early diagnosis of nonalcoholic fatty liver disease (NAFLD) is urgently needed. Here, we aimed to identify NAFLD biomarkers in the early stages of...
4.
Velazquez-Enriquez J, Reyes-Avendano I, Santos-Alvarez J, Reyes-Jimenez E, Vasquez-Garzon V, Baltierrez-Hoyos R
Adv Respir Med
. 2023 Oct;
91(5):407-431.
PMID: 37887075
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and irreversible disease with a high mortality rate worldwide. However, the etiology and pathogenesis of IPF have not yet been fully...
5.
Ramirez-Hernandez A, Reyes-Jimenez E, Velazquez-Enriquez J, Santos-Alvarez J, Soto-Guzman A, Castro-Sanchez L, et al.
Cells
. 2023 Jul;
12(14).
PMID: 37508515
Idiopathic pulmonary fibrosis (IPF) is the most frequent and severe idiopathic interstitial pneumonia. It is a chronic and progressive disease with a poor prognosis and is a major cause of...
6.
Reyes-Jimenez E, Ramirez-Hernandez A, Santos-Alvarez J, Velazquez-Enriquez J, Gonzalez-Garcia K, Carrasco-Torres G, et al.
Int Immunopharmacol
. 2023 Jul;
122:110664.
PMID: 37481854
Systemic sclerosis (SSc) is an autoimmune disease characterized by microvascular compromise and fibrosis. Pulmonary fibrosis, a prominent pulmonary complication in SSc, results in impaired lung function due to excessive accumulation...
7.
Perez-Figueroa D, Reyes-Jimenez E, Velazquez-Enriquez J, Reyes-Avendano I, Gonzalez-Garcia K, Villa-Trevino S, et al.
Iran J Basic Med Sci
. 2023 Jul;
26(7):760-767.
PMID: 37396951
Objectives: Systemic sclerosis (SSc) is an autoimmune disease of unknown etiology with a high mortality rate. Renal crisis has been reported as one of the predictors of early mortality in...
8.
Santos-Alvarez J, Velazquez-Enriquez J, Garcia-Carrillo R, Rodriguez-Beas C, Ramirez-Hernandez A, Reyes-Jimenez E, et al.
Cells
. 2022 Apr;
11(7).
PMID: 35406675
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease. Lesions in the lung epithelium cause alterations in the microenvironment that promote fibroblast accumulation. Extracellular vesicles (EVs) transport proteins, lipids,...
9.
Reyes-Avendano I, Reyes-Jimenez E, Gonzalez-Garcia K, Perez-Figueroa D, Baltierrez-Hoyos R, Tapia-Pastrana G, et al.
Antioxidants (Basel)
. 2022 Feb;
11(2).
PMID: 35204240
Hepatocellular carcinoma (HCC) is a health problem worldwide due to its high mortality rate, and the tumor microenvironment (TME) plays a key role in the HCC progression. The current ineffective...
10.
Ramirez-Hernandez A, Velazquez-Enriquez J, Santos-Alvarez J, Lopez-Martinez A, Reyes-Jimenez E, Carrasco-Torres G, et al.
Cells
. 2022 Feb;
11(4).
PMID: 35203281
Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease of unknown etiology. Different types of cells are involved in fibrogenesis, which is persistently physical and molecular stimulation, either directly...